License and Devlopment Agreement between Genentech, Inc., and SurModics, Inc.Master Service Agreement • February 5th, 2010 • Surmodics Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 5th, 2010 Company Industry JurisdictionThis License and Development Agreement (“Agreement”) is made and entered into as of the 5th day of October, 2009 (the “Effective Date”) by and between SurModics, Inc., a Minnesota corporation with a principal place of business at 9924 West 74th Street, Eden Prairie MN 55344 (together with its Affiliates, “SurModics”), Genentech, Inc., a Delaware corporation, with offices located at 1 DNA Way, South San Francisco, CA 94080 (“GNE”) and F. Hoffmann-La Roche, Ltd., Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche together referred to as “Genentech”). SurModics and Genentech are each referred to herein individually as a “Party” and collectively as the “Parties.”
MASTER SERVICE AGREEMENT by and between Genentech, Inc., and SurModics, Inc.Master Service Agreement • February 5th, 2010 • Surmodics Inc • Pharmaceutical preparations
Contract Type FiledFebruary 5th, 2010 Company IndustryTHIS MASTER SERVICE AGREEMENT (the “MSA”) is entered into as of the 5th day of October 2009 (“Effective Date”) by and between Genentech, Inc., a Delaware corporation, with offices located at 1 DNA Way, South San Francisco, CA 94080 (“GNE”) and F. Hoffmann-La Roche, Ltd., Grenzacherstrasse 124, CH 4070 Basel, Switzerland (“Roche”) (GNE and Roche together referred to as “Genentech”) and SurModics, Inc. a Minnesota corporation with a principal place of business at 9924 West 74th Street, Eden Prairie, MN 55344 (SurModics, Inc. together with its Affiliates hereinafter referred to as “SurModics”) (each individually a “Party” and collectively, the “Parties”).